Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITGB3 | P05106 | 2/20 | 0.47 |
| ▸ | ITGA2B | P08514 | 2/20 | 0.47 |
| ▸ | PIN1 | Q13526 | 1/20 | 0.47 |
| ▸ | GNPAT | O15228 | 1/20 | 0.47 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.43 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.42 |
| ▸ | GRIA1 | P42261 | 1/20 | 0.42 |
| ▸ | CTSG | P08311 | 1/20 | 0.42 |
| ▸ | CMA1 | P23946 | 1/20 | 0.42 |
| ▸ | MMP1 | P03956 | 1/20 | 0.42 |
| ▸ | MMP2 | P08253 | 1/20 | 0.42 |
| ▸ | MMP3 | P08254 | 1/20 | 0.42 |
| ▸ | MMP7 | P09237 | 1/20 | 0.42 |
| ▸ | CTSL | P07711 | 1/20 | 0.42 |
| ▸ | MME | P08473 | 1/20 | 0.41 |
| ▸ | ACE | P12821 | 1/20 | 0.41 |
| ▸ | CPA1 | P15085 | 1/20 | 0.41 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5966639 | 1.00 | ITGB3 (0.47) | ITGB3ITGA2BPIN1GNPATHDAC8 | |
| SCHEMBL10827295 | 0.83 | PIN1 (0.56) | ITGB3ITGA2BPIN1HDAC8PTPN1 | |
| SCHEMBL18797858 | 0.83 | LTA4H (0.45) | MMEACE | |
| SCHEMBL27608485 | 0.80 | SLC15A2 (0.56) | PIN1GNPAT | |
| SCHEMBL27608488 | 0.80 | SLC15A2 (0.56) | PIN1GNPAT | |
| SCHEMBL2704790 | 0.80 | MME (0.53) | ITGB3ITGA2BPIN1GNPATHDAC8 | |
| SCHEMBL8699341 | 0.79 | ITGB3 (0.49) | ITGB3ITGA2BHDAC8PTPN1MME | |
| SCHEMBL5598794 | 0.79 | MME (0.46) | ITGB3ITGA2BGNPATMMP2MMP7 | |
| SCHEMBL5598789 | 0.79 | MME (0.46) | ITGB3ITGA2BGNPATMMP2MMP7 | |
| SCHEMBL30692732 | 0.79 | MME (0.46) | ITGB3ITGA2BGNPATMMP2MMP7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060128613-A1 | Melanocortin receptor ligands | THE PROCTER & GAMBLE COMPANY | 2006-06-15 | — | — | US | disclosed |
| CN-1571796-A | Melanocortin receptor ligands | PROCTER & GAMBLE (US) | 2005-01-26 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060128613-A1 | Melanocortin receptor ligands | MC3R, MC4R, MC1R | ITGB3 788/4885ITGA2B 2088/4885PIN1 4199/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.